Procept BioRobotics Sued for Securities Law Violations
DJS Law Group has notified investors of a class action lawsuit filed against Procept BioRobotics Corporation. The suit alleges violations of securities laws by the company.
DJS Law Group has informed investors about a class action lawsuit initiated against Procept BioRobotics Corporation (NASDAQ: PRCT). The lawsuit alleges the company violated Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder.
The complaint asserts that Procept BioRobotics made misleading statements and failed to disclose material information regarding its Aquablation technology, used for treating benign prostatic hyperplasia. Investors who purchased Procept securities during a specified period may have suffered losses as a result of these alleged misrepresentations.
The class action seeks to represent all investors who incurred financial losses due to the allegedly false and misleading statements made by the company. DJS Law Group is encouraging potential class members to contact the firm to discuss their rights and options regarding participation in the litigation.
The lawsuit is currently proceeding in federal court. Further details concerning the legal proceedings and the specific class period are available through DJS Law Group.